Correction: Evaluation of bleeding events in patients receiving acalabrutinib therapy
Leukemia
.
2023 Jul;37(7):1588.
doi: 10.1038/s41375-023-01927-8.
Authors
Pooja S Kumar
1
,
Tracy Wiczer
1
,
Lindsay Rosen
1
,
Arthur J Pollauf
2
,
Amy Zheng
2
,
Marilly Palettas
3
,
Leylah Azali
4
,
Seema A Bhat
5
,
John C Byrd
6
,
Michael R Grever
5
,
Kerry A Rogers
5
,
Jennifer A Woyach
5
,
Adam S Kittai
7
Affiliations
1
The Ohio State University, Department of Pharmacy, Columbus, OH, USA.
2
The Ohio State College of Pharmacy, Columbus, OH, USA.
3
The Ohio State University, Department of Biomedical Informatics, Center for Biostatistics, Columbus, OH, USA.
4
Driscoll Children's Hospital, Corpus Christi, TX, USA.
5
The Ohio State University, Department of Internal Medicine, Division of Hematology, Columbus, OH, USA.
6
University of Cincinnati, Department of Internal Medicine, Cincinnati, OH, USA.
7
The Ohio State University, Department of Internal Medicine, Division of Hematology, Columbus, OH, USA. adam.kittai@osumc.edu.
PMID:
37231141
DOI:
10.1038/s41375-023-01927-8
No abstract available
Publication types
Published Erratum